{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:49:00Z","timestamp":1790336940183,"version":"4.1.0"},"reference-count":27,"publisher":"European Respiratory Society (ERS)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2003,2,14]]},"published-print":{"date-parts":[[2003,8]]},"abstract":"<jats:p>Primary pulmonary hypertension (PPH) is a life-threatening disease. Nonparenteral prostanoids,<jats:italic>i.e.<\/jats:italic>aerosolised iloprost or oral beraprost sodium show beneficial therapeutic effects but are not sufficiently active in all patients with this devastating disease. The purpose of the present study was to determine whether the endothelin-receptor antagonist bosentan is safe and effective in patients with PPH already receiving nonparenteral prostanoids.<\/jats:p><jats:p>The effect of bosentan as add-on medication was studied in 20 patients with PPH, who received either inhaled iloprost (n=9) or oral beraprost (n=11) for a median period of 16\u00b113 months, by means of the 6\u2010min walk test and cardiopulmonary exercise testing.<\/jats:p><jats:p>After 3 months of administration of bosentan in addition to prostanoids, the walking distance in the 6\u2010min walk test increased by 58\u00b143\u2005m. Cardiopulmonary exercise testing revealed an increase in maximal oxygen consumption from 11.0\u00b12.3 to 13.8\u00b13.6\u2005mL\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7min<jats:sup>\u22121<\/jats:sup>accompanied by significant improvements in anaerobic threshold, oxygen pulse and minute ventilation\/carbon dioxide production slope. Peak systolic blood pressure increased from 120\u00b117 to 139\u00b121\u2005mmHg. Combination treatment was well tolerated by all patients.<\/jats:p><jats:p>It is concluded that the addition of the endothelin-receptor antagonist bosentan to inhaled iloprost or oral beraprost therapy appears to be safe for patients with primary pulmonary hypertension, resulting in a marked increase in exercise capacity. Therefore, rigorous studies should address whether combination treatment is more effective than either therapeutic intervention alone.<\/jats:p>","DOI":"10.1183\/09031936.03.00008003","type":"journal-article","created":{"date-parts":[[2003,7,29]],"date-time":"2003-07-29T21:02:12Z","timestamp":1059512532000},"page":"330-334","source":"Crossref","is-referenced-by-count":140,"title":["Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids"],"prefix":"10.1183","volume":"22","author":[{"given":"M.M.","family":"Hoeper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bekjarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gatzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Spiekerkoetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2003,8,1]]},"reference":[{"key":"2024101810241484000_22.2.330.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701093360207"},{"key":"2024101810241484000_22.2.330.2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","volume":"115","year":"1991","journal-title":"Ann Intern Med"},{"key":"2024101810241484000_22.2.330.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602013340504"},{"key":"2024101810241484000_22.2.330.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801293380501"},{"key":"2024101810241484000_22.2.330.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02012-0"},{"key":"2024101810241484000_22.2.330.6","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000029100.82385.58"},{"key":"2024101810241484000_22.2.330.7","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.6.2106079"},{"key":"2024101810241484000_22.2.330.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01786-2"},{"key":"2024101810241484000_22.2.330.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020204"},{"key":"2024101810241484000_22.2.330.10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.02462001"},{"key":"2024101810241484000_22.2.330.11","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.19.2434"},{"key":"2024101810241484000_22.2.330.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06250-X"},{"key":"2024101810241484000_22.2.330.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012212"},{"key":"2024101810241484000_22.2.330.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01911-3"},{"key":"2024101810241484000_22.2.330.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00494-5"},{"key":"2024101810241484000_22.2.330.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422503"},{"key":"2024101810241484000_22.2.330.17","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.17100140"},{"key":"2024101810241484000_22.2.330.18","first-page":"919","volume":"132","year":"1985","journal-title":"Can Med Assoc J"},{"key":"2024101810241484000_22.2.330.19","doi-asserted-by":"publisher","DOI":"10.1161\/hc2901.093198"},{"key":"2024101810241484000_22.2.330.20","doi-asserted-by":"publisher","DOI":"10.1161\/hc0102.101509"},{"key":"2024101810241484000_22.2.330.21","unstructured":"Wasserman K, Hansen JE, Sue DY.. Principles of Exercise Testing and InterpretationBaltimore, MD, Lippincott Williams & Wilkens, 1999."},{"key":"2024101810241484000_22.2.330.22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.20.2388"},{"key":"2024101810241484000_22.2.330.23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.5.1566"},{"key":"2024101810241484000_22.2.330.24","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.2.9906015"},{"key":"2024101810241484000_22.2.330.25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000022687.18568.2A"},{"key":"2024101810241484000_22.2.330.26","doi-asserted-by":"publisher","DOI":"10.1177\/00912709922008380"},{"key":"2024101810241484000_22.2.330.27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2165\/00003088-199630060-00002","volume":"30","year":"1996","journal-title":"Clin Pharmacokinet"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.03.00008003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:42:17Z","timestamp":1740375737000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.03.00008003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2003,8,1]]},"published-print":{"date-parts":[[2003,8]]}},"alternative-id":["10.1183\/09031936.03.00008003"],"URL":"https:\/\/doi.org\/10.1183\/09031936.03.00008003","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}